Drug Use Investigation On Zithromac (Azithromycin) In HIV Patients

Pfizer

Status: Completed

Conditions: HIV Infection

Treatments: Drug: Azithromycin

Study type: Observational

Funder types: Industry

Identifiers

NCT01227395

A0661097

Details and patient eligibility

About

The investigation will be conducted for the purpose of determining the condition of occurrence of Adverse Events under the actual post-marketing use of Zithromac 600mg Tablet, verifying the therapeutic effects, detecting unknown Adverse Drug Reactions and drug interactions and determining the factors affecting safety and efficacy.

Full description

All the patients whom an investigator prescribes the first Zithromac Tablets 600mg should be registered consecutively until the number of subjects reaches target number in order to extract patients enrolled into the investigation at random.

Enrollment: 476 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

Patients need to be administered Zithromac Tablets 600mg in order to be enrolled in the surveillance.

Exclusion criteria

Patients not administered Zithromac Tablets 600mg.

Trial design

476 participants in 1 patient group

Azithromycin

Description:

Patients taking Azithromycin.

Treatment:

Drug: Azithromycin